Literature DB >> 11359293

Neuropathic orofacial pain part 1--prevalence and pathophysiology.

E R Vickers1, M J Cousins.   

Abstract

Neuropathic pain is defined as "pain initiated or caused by a primary lesion or dysfunction in the nervous system". Neuropathic orofacial pain has previously been known as "atypical odontalgia" (AO) and "phantom tooth pain". The patient afflicted with neuropathic oral/orofacial pain may present to the dentist with a persistent, severe pain, yet there are no clearly identifiable clinical or radiographic abnormalities. Accordingly, multiple endodontic procedures may be instigated to remove the likely anatomical source of the pain, yet the pain persists. There have been few studies and limited patient numbers investigating the condition. Two retrospective studies revealed the incidence of persistent pain following endodontic treatment to be 3-6% and 5% of patients; one author with wide experience in assessing the condition estimated its prevalence at 125,000 individuals in the USA alone. In one study, 50% of neuropathic orofacial pain patients reported persistent pain specifically following endodontic treatment. Patients predisposed to the condition may include those suffering from recurrent cluster or migraine headaches. Neuropathic pain states include postherpetic neuralgia (shingles) and phantom limb/stump pain. The aberrant developmental neurobiology leading to this pain state is complex. Neuropathic pain serves no protective function, in contrast to physiological pain that warns of noxious stimuli likely to result in tissue damage. The relevant clinical features of neuropathic pain include: (i) precipitating factors such as trauma or disease (infection), and often a delay in onset after initial injury (days-months), (ii) typical complaints such as dysaesthesias (abnormal unpleasant sensations), pain that may include burning, and paroxysmal, lancinating or sharp qualities, and pain in an area of sensory deficit, (iii) on physical examination there may be hyperalgesia, allodynia and sympathetic hyperfunction, and (iv) the pathophysiology includes deafferentation, nerve sprouting, neuroma formation and sympathetic efferent activity.

Entities:  

Mesh:

Year:  2000        PMID: 11359293     DOI: 10.1111/j.1747-4477.2000.tb00146.x

Source DB:  PubMed          Journal:  Aust Endod J        ISSN: 1329-1947            Impact factor:   1.659


  9 in total

1.  An improved behavioural assay demonstrates that ultrasound vocalizations constitute a reliable indicator of chronic cancer pain and neuropathic pain.

Authors:  Martina Kurejova; Ulrike Nattenmüller; Ullrich Hildebrandt; Deepitha Selvaraj; Sebastian Stösser; Rohini Kuner
Journal:  Mol Pain       Date:  2010-03-26       Impact factor: 3.395

2.  Fibronectin inhibits chronic pain development after spinal cord injury.

Authors:  Ching-Yi Lin; Yu-Shang Lee; Vernon W Lin; Jerry Silver
Journal:  J Neurotrauma       Date:  2012-01-13       Impact factor: 5.269

3.  Indwelling supradural catheters for induction of facial allodynia: surgical procedures, application of inflammatory stimuli, and behavioral testing.

Authors:  Julie Wieseler; David Sprunger; Amanda Ellis; Steven F Maier; Linda R Watkins
Journal:  Methods Mol Biol       Date:  2012

4.  A novel method for modeling facial allodynia associated with migraine in awake and freely moving rats.

Authors:  Julie Wieseler; Amanda Ellis; David Sprunger; Kim Brown; Andrew McFadden; John Mahoney; Niloofar Rezvani; Steven F Maier; Linda R Watkins
Journal:  J Neurosci Methods       Date:  2009-10-29       Impact factor: 2.390

Review 5.  Challenges in the development of novel treatment strategies for neuropathic pain.

Authors:  Michael H Ossipov; Frank Porreca
Journal:  NeuroRx       Date:  2005-10

6.  Current evidence on atypical odontalgia: diagnosis and clinical management.

Authors:  Yoshihiro Abiko; Hirofumi Matsuoka; Itsuo Chiba; Akira Toyofuku
Journal:  Int J Dent       Date:  2012-07-09

7.  Pain management procedures used by dental and maxillofacial surgeons: an investigation with special regard to odontalgia.

Authors:  Stefan Wirz; Hans Christian Wartenberg; Joachim Nadstawek
Journal:  Head Face Med       Date:  2005-12-22       Impact factor: 2.151

8.  Patients with persistent idiopathic dentoalveolar pain in dental practice.

Authors:  Frank Sanner; David Sonntag; Norbert Hambrock; Matthias Zehnder
Journal:  Int Endod J       Date:  2021-12-02       Impact factor: 5.165

9.  Altered pain modulation in patients with persistent postendodontic pain.

Authors:  Cibele Nasri-Heir; Junad Khan; Rafael Benoliel; Changyong Feng; David Yarnitsky; Fengshen Kuo; Craig Hirschberg; Gary Hartwell; Ching-Yu Huang; Gary Heir; Olga Korczeniewska; Scott R Diehl; Eli Eliav
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.